896155-81-0

Usage

Uses

Used in Pharmaceutical Synthesis:
2-(Benzyloxy)-4-iodopyridine is used as a key intermediate in the synthesis of various pharmaceuticals and organic compounds. Its unique structure allows for the creation of complex molecules, making it a versatile component in drug development.
Used in Organic Chemistry Research:
In the field of organic chemistry, 2-(Benzyloxy)-4-iodopyridine serves as a building block for constructing complex organic molecules. Its presence in reactions can lead to the formation of new compounds with potential applications in various industries.
Used in Drug Development:
2-(Benzyloxy)-4-iodopyridine is used as a lead compound in drug development due to its potential biological activity. Its unique properties may contribute to the discovery of new therapeutic agents, particularly in the context of medicinal chemistry.
Used in Academic and Industrial Settings:
The versatile properties of 2-(Benzyloxy)-4-iodopyridine make it valuable in both academic research for understanding chemical reactions and mechanisms, as well as in industrial applications for the production of specialty chemicals and pharmaceuticals.

Upstream product

• 22282-70-8 2-fluoro-4-iodopyridine 
• 100-51-6 benzyl alcohol 
• 372-48-5 2-fluoropyridine 
• 113975-22-7 2-fluoro-3-iodopyridine 

Downstream Products

• 896155-82-1 2-(benzyloxy)-4-[3-decyloxy-5-(tert-butyldimethylsilanyloxymethyl)phenyl]pyridine 
• 847946-93-4 3-decyloxy-5-(2-benzyloxy-pyrid-4-yl)-benzaldehyde 
• 942947-15-1 3-(2-(benzyloxy)pyridin-4-yl)-2-chloro-6-(trifluoromethyl)pyridine 

Relevant academic research and scientific papers

Vanilloid receptor ligands and their use in treatments

Substituted pyridines and pyrimidines and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache,

Modulation of the reactivity, stability and substrate- and enantioselectivity of an epoxidation catalyst by noncovalent dynamic attachment of a receptor functionality - Aspects on the mechanism of the Jacobsen-Katsuki epoxidation applied to a supramolecular system

The synthesis of the components of the dynamic supramolecular hydrogen-bonded catalytic system 2 + 3 is described. The catalytic performance and substrate- and enantioselectivity of Mn(salen) catalyst 2 were investigated in the presence and absence of the Zn(porphyrin) receptor unit 3. The effects of pyridine and pyridine N-oxide donor ligands were also studied. Some aspects on the mechanism of the Jacobsen-Katsuki epoxidation, based on literature observations, are introduced as a means to analyse the behaviour of 2 and its modulation by the formation of macrocycle 1 with 3. A complete association model of the metal-free system 4 + 5 refutes the earlier assumption that macrocycle 1 is the predominant form of catalyst 2 under the standard epoxidation reaction conditions with 2 + 3. Evidence are provided that receptor-binding substrates and nonbinding substrates, respectively, are epoxidised by two different catalytic species, or two distinct distributions of species in competitive epoxidations using catalytic system 2 + 3. The two species are assigned to the endo and exo faces of the Mn(salen) catalyst in macrocycle 1, and to equivalently folded oligomeric structures with monomers 2 and 3 in adjacent positions. The Royal Society of Chemistry 2006.